SLC10A2
SLC10A2 is a gene that encodes the sodium-dependent bile acid transporter protein, also known as the apical sodium-bile acid transporter (ASBT), in humans. This protein is crucial for the reabsorption of bile acids from the intestine. The SLC10A2 gene is located on chromosome 13 in humans and plays a significant role in the enterohepatic circulation of bile acids.
Function[edit | edit source]
The protein encoded by SLC10A2 is involved in the active transport and reabsorption of bile acids in the ileum, the final section of the small intestine. Bile acids are critical for the digestion and absorption of fats and fat-soluble vitamins in the small intestine. The efficient reabsorption of bile acids via ASBT in the ileum conserves these molecules for recirculation to the liver, thus minimizing the need for de novo synthesis of bile acids from cholesterol.
Clinical Significance[edit | edit source]
Mutations in the SLC10A2 gene can lead to a condition known as primary bile acid malabsorption (PBAM), which is characterized by chronic diarrhea and malabsorption of fats. Patients with this condition have a reduced ability to reabsorb bile acids in the ileum, leading to an increased fecal loss of bile acids and subsequent diarrhea.
Genetic Regulation[edit | edit source]
The expression of SLC10A2 is regulated by various nuclear receptors, including the farnesoid X receptor (FXR), which plays a pivotal role in the regulation of bile acid levels in the liver and intestine. Activation of FXR in the ileum induces the expression of SLC10A2, thereby enhancing the reabsorption of bile acids.
Research[edit | edit source]
Research on SLC10A2 has focused on understanding its role in bile acid homeostasis and its implications in gastrointestinal diseases. Studies have also explored the potential of targeting ASBT with inhibitors as a therapeutic strategy for hypercholesterolemia and other metabolic disorders, by reducing the recirculation of bile acids and increasing their excretion.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
